⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22157510 | 0.85 | — | — | |
| SCHEMBL22419900 | 0.83 | ADH1B (0.61) | — | |
| SCHEMBL22157532 | 0.83 | ADH1B (0.61) | — | |
| SCHEMBL13537369 | 0.81 | ADH1B (0.64) | — | |
| SCHEMBL13494685 | 0.78 | — | — | |
| SCHEMBL14096885 | 0.78 | — | — | |
| SCHEMBL21228677 | 0.77 | — | — | |
| SCHEMBL22157365 | 0.76 | TAS1R3 (0.35) | — | |
| SCHEMBL543188 | 0.76 | — | — | |
| SCHEMBL23266988 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3884019-B1 | HOME CARE COMPOSITIONS | COLGATE PALMOLIVE CO (US) | 2025-09-03 | — | — | EP | disclosed |
| EP-3884019-A1 | HOME CARE COMPOSITIONS | Colgate-Palmolive Company (US) | 2021-09-29 | — | — | EP | disclosed |
| CN-113227340-A | Home care compositions | 高露洁-棕榄公司 | 2021-08-06 | — | — | CN | disclosed |
| US-11008533-B2 | Home care compositions | COLGATE-PALMOLIVE COMPANY (US) | 2021-05-18 | — | — | US | disclosed |
| WO-2020139335-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | WO | disclosed |
| US-20200208081-A1 | HOME CARE COMPOSITIONS | COLGATE-PALMOLIVE COMPANY (US) | 2020-07-02 | — | — | US | disclosed |
| EP-1317424-A2 | POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | MediQuest Therapeutics, Inc. (US) | 2003-06-11 | — | — | EP | disclosed |
| EP-1296931-A2 | POLYAMINE ANALOGUES AS CYTOTOXIC AGENTS | MediQuest Therapeutics, Inc. (US) | 2003-04-02 | — | — | EP | disclosed |
| WO-2001072685-A9 | POLYAMINE ANALOGUES AS CYTOTOXIC AGENTS | ORIDIGM CORP (US) | 2002-10-10 | — | — | WO | disclosed |
| US-20020091254-A1 | Stabilizing and/or lowering the color number of alkenyl compounds | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-11 | — | — | US | disclosed |
| US-6384216-B1 | CARRYING OUT TWO DISTILLATIONS IN WHICH THE PURIFIED ALKENYL COMPOUNDS OBTAINED FROM GAS PHASE BY CONDENSATION, WHERE THE TIME BETWEEN FIRST DISTILLATION AFTER SYNTHESIS OF ALKENYL COMPOUNDS AND FURTHER DISTILLATION | BASF AKTIENGESELLSCHAFT (DE) | 2002-05-07 | — | — | US | disclosed |
| US-20020038059-A1 | PURIFICATION OF ALKENYL COMPOUNDS | BASF AKTIENGESELLSCHAFT (DE) | 2002-03-28 | — | — | US | disclosed |
| WO-2001092218-A2 | POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2001-12-06 | — | — | WO | disclosed |
| WO-2001072685-A2 | POLYAMINE ANALOGUES AS CYTOTOXIC AGENTS | ORIDIGM CORPORATION (US) | 2001-10-04 | — | — | WO | disclosed |
| EP-1001927-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999003823-A2 | NOVEL POLYAMINE ANALOGUES AS THERAPEUTIC AND DIAGNOSTIC AGENTS | ORIDIGM CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |